IN DATA

Powered by 

Pharma subsidiaries

Deals analysis

Rankings

Economic data

Macro-economic indicators

INSIDE THE DEAL

Imcyse closes €21.3m Series B funding round

Imcyse has secured funding to continue developing novel immunotherapies for severe autoimmune diseases

Deals Analysis

Aquisitions lead in total deal value by type

Despite boasting modest deal count numbers, aquisitions vastly overshadow other deal types in value

Rankings

Who's leading in Europe in terms of R&D expenditure

Our pharma industry key list brings you the 15 leading emerging companies in Europe by revenue

Pharma subsidiaries

Deals analysis

Rankings

Economic data

Macro-economic indicators

02/23/2024 23:27:17
  • Home | Waive goodbye to vaccine patents
  • In this issue
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Datwyler
  • Datwyler Company Insight
  • Labcorp
  • Biesterfeld
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Dr. Paul Lohmann
  • Butterworth
  • Skyepharma
  • Baxter
  • Comment
  • Speeding up patient access to innovative drugs
  • The competitive landscape of neoantigen-targeting therapeutics in oncology
  • Bacterial “cell factories”: an eco-friendly approach to chemical production
  • MDR set to transform how MedTech firms approach content management
  • PerkinElmer
  • Nipro
  • Nipro
  • In Depth
  • Should UK children be vaccinated against chickenpox?
  • Fighting India’s ‘black fungus’ epidemic
  • What could a vaccine patent waiver mean for pharma manufacturing? 
  • Algae proteins: a vision of the future
  • A brief history of ALS awareness and its sparse treatments 
  • Ferring draws closer to a microbiome breakthrough
  • The Solubility company
  • Myonex
  • Owen Mumford
  • In Data
  • Data: pharma subsidiaries
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
07/22/2021 00:00:00